Product Benefits

LVIS® and LVIS® Jr. devices are braided coil assist stents used for aneurysm embolization.

  1.  
  • The braided construction allows physicians to control the stent deployment to achieve optimal placement. Radiopaque strands along the entire stent body allow physicians to visualize the stent expansion.

  • The braided design allows individual wires to slide during deployment, allowing the stent to conform to the shape of the vessel, even in tortuous anatomies.

  • The high metal coverage and small pore size provide consistent support of coil mass including small finishing coils.

The LVIS Device.   *The blue wire denotes the radiopaque stent body material

The LVIS Device. *The blue wire denotes the radiopaque stent body material

The LVIS Device.   *The blue wire denotes the radiopaque stent body material

The LVIS Device. *The blue wire denotes the radiopaque stent body material

The LVIS Jr. Device.   *The blue wire denotes the radiopaque stent body material

The LVIS Jr. Device. *The blue wire denotes the radiopaque stent body material

The LVIS Jr. Device.   *The blue wire denotes the radiopaque stent body material

The LVIS Jr. Device. *The blue wire denotes the radiopaque stent body material

Specifications

Product Compatibility:

The LVIS® Device is compatible with the Headway® 21 Microcatheter

The LVIS® Jr. Device is compatible with the Headway® 17 Microcatheter, Scepter C®, and Scepter XC® Occlusion Balloons.

Clinical Evidence

Primary Effectiveness Composite Success2 : 70.6% (108/153)

100% aneurysm occlusion without clinically significant in stent stenosis or target aneurysm retreatment

0%

90%-100% Aneurysm Occlusion3 

N=(127/139)

0%

Clinically Significant In-Stent Stenosis (≥ 50%) Of Parent Artery

N=(0/139)

0%

Target Aneurysm Retreatment

N=(6/139)

0%

Disabling Stroke With mRS Score ≥ 34 

N=(6/153)

0%

Neurological Death

N=(3/153)

0%

Learn More

Aneurysm Therapy Solutions

Learn more about MicroVention's groundbreaking disease treatments.

Learn More

Clinical Education

Find clinical trials, studies and registries involving this product. Visit clinicaltrials.gov for more information.

Learn More

How to Order

Visit our contact page for information on how to place an order by phone, fax or email.

Learn More
  1. 1

    Sizes are not approved or available in certain regions. Please contact your local sales representative for region specific sizing

  2. 2

    ITT (intended to treat) population N=153. All missing patients were considered failures

    All LVIS PMA pivotal study data based on FDA Approval P170013

  3. 3

    RR Class 1 (N=111) + RR Class 2 with stable or positive occlusion and no retreatment (N=16). Subjects having negative progression from post-procedure to 12 months or retreatment are considered failures. Missing data imputed as failures

  4. 4

    mRS score ≥ 3 at any time point between 90 days and last available follow-up. 2 major strokes were caused by pre-existing morbidities and were in vascular territories unrelated to device or procedure

TITLE

ADDRESS_TEXT

    PHONE LIST